Bill Tawil

Enhancing tissue engineering/regenerative medical product commercialization: the role of science in regulatory decision making for tissue engineering/regenerative medicine product development.

Timothy A Bertram, Kiki B Hellman, Peter C Johnson, 2013, Tissue engineering. Part A.

The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure.

Benjamin M Wu, Benjamin M. Wu, Bill Tawil, 2006, Tissue engineering.

Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry.

Timothy A Bertram, Kiki B Hellman, Peter C Johnson, 2011, Tissue engineering. Part A.

Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.

Timothy A Bertram, Kiki B Hellman, Peter C Johnson, 2012, Tissue engineering. Part A.

Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.

Bill Tawil, Steve Cox, Marietta Cole, 2004, Tissue engineering.

Human U937 monocyte behavior and protein expression on various formulations of three‐dimensional fibrin clots

Bill Tawil, Miyeko Mana, Steve Cox, 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity.

Benjamin Wu, Benjamin M. Wu, Bill Tawil, 2009, Tissue engineering. Part A.